May 13, 2019
NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark  this link  for your convenience.

NCORP SITES

Register today for the NRG-CC004 Webinar on Wednesday, June 19th

Read more


 
 

Register today to have your fee waived!

We hope you can join us for the NRG Oncology Semiannual Meeting, July 18-20, 2019, at the Philadelphia Marriott Downtown in Philadelphia, PA. Pre-Registration for this meeting is complimentary for all NRG members who pre-register by the deadline of June 25, 2019. We kindly ask that everyone please pre-register for this meeting before the deadline. Onsite registration will incur a $100 fee. 

Registration and meeting information is available on the NRG Oncology website.

 

Patient-Reported Outcomes: Upping the game for PRO methods and design in clinical trials

NRG Oncology will be holding a workshop at the NRG Semiannual Meeting related to improving statistical methods to meet study goals and analyzing longitudinal PRO data. This session will also include a panel discussion with NCORP PIs. The session will be held on Thursday, July 18, 2019 from 1:00-5:00 PM ET and will be open to all attendees. More information on the session and agenda will be released soon.


AMENDMENT
GYNECOLOGIC

NRG-GY016: Amendment 3; version date: April 22, 2019 (posted on CTSU)


OTHER PROTOCOL NOTICES

1. GYNECOLOGIC

NRG-GY009: Block Submission Reminder memo (posted on CTSU)

 

Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more

 

Biospecimen Bank-Columbus & SDMC Undergoing Refurbishment Read more

 

2. HEAD & NECK

NRG-HN004: CCTG has received regulatory approval and will act as the sponsor in Canada. The trial was activated in Canada on May 10, 2019. Sites in Canada will be required to participate through CCTG for this study. Further questions and logistics for activation can be directed to:Chad Winch ( cwinch@ctg.queensu.ca


3. NCORP

NCORP SitesRegister today for the NRG-CC004 webinar. Please continue to screen patients for this important trial. Read more

 

4. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for Wednesday, June 12.

DRUG SAFETY UPDATES AND INVESTIGATOR'S BROCHURE NOTICES

Safety updates and Investigator's Brochure notices have been issued for the following studies:

 

DRUG NAME

PROTOCOL

WEBSITE FOR SAFETY REPORTS

INVESTIGATOR'S BROCHURE (IB)*

Atezolizumab

NRG-GY009

NRG-GY017

CTSU

NRG

 

 

Durvalumab

NRG-HN004

NRG-LU004

CTSU

NRG

 

 

Ipilimumab

NRG-BN002

NRG-GY003

NRG

NRG

X

X

Nivolumab

NRG-BN002

NRG-GY003

NRG

NRG

 

 

Olaparib

NRG-GY004

NRG-GY005
NRG-GY012

 

 

X

X
X

 

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website ( https://ctepcore.nci.nih.gov/OAOP/ ). Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

 

REGISTER TODAY! Webinar for NRG-CC004

 

NRG Oncology will be holding a webinar for NRG-CC004: Phase II Double Blind Dose Finding Trial of Bupropion versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer. The webinar will occur on Wednesday, June 19 from 4:00-5:00 PM ET.

 

Register at: https://attendee.gotowebinar.com/register/4196058926907886595

Please contact Angie LaPenta at lapentaa@nrgoncology.org with any questions.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

 

JOURNAL ARTICLES

Kruser TJ, Bosch WR, Badiyan SN, Bovi JA, Ghia AJ, Kim MM, Solanki AA, Sachdev S, Tsien C, Wang TJC, Mehta MP, McMullen KP. NRG brain tumor specialists consensus guidelines for glioblastoma contouring. J Neurooncol. 2019 May;143(1):157-166. doi: 10.1007/s11060-019-03152-9. Epub 2019 Mar 19. PubMed PMID: 30888558; PubMed Central PMCID: PMC6483830.   Read more

Winter K, Pugh SL. An investigator's introduction to statistical considerations in clinical trials. Urol Oncol. 2019 May;37(5):305-312. doi: 10.1016/j.urolonc.2018.12.025. Epub 2019 Mar 26. Review. PubMed PMID: 30926221.   Read more


PUBLICATIONS REMINDERS

Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings

American College of Radiology (ACR); May 18-22, 2019 ; Washington DC


American Society of Clinical Oncology (ASCO)
; May 31 - Jun 4, 2019; Chicago, IL


American Society of Colon and Rectal Surgeons (ASCRS)
; Jun 1-5, 2019; Cleveland, OH


Society for Clinical Trials (SCT)
; May 19-22, 2019; New Orleans, LA

 

Upcoming Abstract Submission Deadlines

European Society for Medical Oncology (ESMO); Sep 27-Oct 1, 2019; Barcelona, Spain; LBA Aug 21, 2019 9:00 PM CEST

Society for Neuro-Oncology (SNO); Nov 20-24, 2019; Phoenix, AZ; due to publications committee May 27, 2019; meeting submission deadline June 10, 2019

 

 

 

NRG Oncology is proud to be an active participant of #CancerMoonShot.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse